文献速递脑血管病

大血管闭塞取栓前静脉溶栓的疗效与安全性

Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions.
PubMed 文献 · Ann Neurol · 2019-07-22

该研究汇总38项观察性研究(共11,798例大血管闭塞的急性缺血性卒中患者),比较桥接治疗(静脉溶栓后取栓)与直接取栓的安全性和有效性;调整分析显示桥接治疗与更高的3个月功能独立率和更低的3个月死亡率相关,且不增加症状性颅内出血。

要点

  • 桥接治疗与3个月功能独立率更高相关(调整OR=1.55,95%CI 1.26-1.91)。
  • 桥接治疗与3个月死亡率更低相关(调整OR=0.80,95%CI 0.66-0.97)。
  • 两组症状性颅内出血无差异(调整OR=0.87,95%CI 0.61-1.25)。

核心结论

  • 对于大血管闭塞的急性缺血性卒中患者,与直接取栓相比,桥接治疗与功能独立改善相关且无安全性担忧。

研究设计与样本

  • 纳入38项观察性研究(含随机对照试验的事后分析),共11,798例大血管闭塞患者,平均年龄68岁,56%接受桥接治疗。

主要发现

  • 未调整分析中,桥接治疗与3个月功能独立(OR=1.52,95%CI 1.32-1.76)、3个月功能改善(cOR=1.52,95%CI 1.18-1.97)、早期神经功能改善(OR=1.21,95%CI 1.83-1.76)、成功再通(OR=1.22,95%CI 1.02-1.46)及≤2次装置取栓成功再通(OR=2.28,95%CI 1.43-3.64)相关,且3个月死亡率更低(OR=0.64,95%CI 0.57-0.73)。
  • 调整分析中,桥接治疗与3个月功能独立(调整OR=1.55,95%CI 1.26-1.91)和更低3个月死亡率(调整OR=0.80,95%CI 0.66-0.97)独立相关。
  • 两组功能改善(调整cOR=1.24,95%CI 0.89-1.74)和症状性颅内出血(调整OR=0.87,95%CI 0.61-1.25)无差异。

临床怎么用

  • 对于大血管闭塞的急性缺血性卒中患者,在机械取栓前进行静脉溶栓(桥接治疗)可能改善功能预后且不增加出血风险。

局限性

  • 研究基于观察性研究,存在选择偏倚等混杂因素;未报告随机对照试验的单独分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The substantial clinical improvement in acute ischemic stroke (AIS) patients treated with mechanical thrombectomy (MT), combined with the poor response of proximal intracranial occlusions to intravenous thrombolysis (IVT), led to questions regarding the utility of bridging therapy (BT; IVT followed by MT) compared to direct mechanical thrombectomy (dMT) for AIS patients with large vessel occlusion (LVO). METHODS: We aimed to investigate the comparative safety and efficacy of BT and dMT in AIS patients. We included all observational studies and post hoc analyses from randomized controlled clinical trials that provided data on the outcomes of AIS patients with LVO stratified by IVT treatment status prior to MT. RESULTS: We identified 38 eligible observational studies (11,798 LVO patients, mean age = 68 years, 56% treated with BT). In unadjusted analyses, BT was associated with a higher likelihood of 3-month functional independence (odds ratio [OR] = 1.52, 95% confidence interval [CI] = 1.32-1.76), 3-month functional improvement (common OR [cOR] for 1-point decrease in modified Rankin Scale score = 1.52, 95% CI = 1.18-1.97), early neurological improvement (OR = 1.21, 95% CI = 1.83-1.76), successful recanalization (OR = 1.22, 95% CI = 1.02-1.46), and successful recanalization with ≤2 device passes (OR = 2.28, 95% CI = 1.43-3.64) compared to dMT. BT was also related to a lower likelihood of 3-month mortality (OR = 0.64, 95% CI = 0.57-0.73). In the adjusted analyses, BT was independently associated with a higher likelihood of 3-month functional independence (adjusted OR = 1.55, 95% CI = 1.26-1.91) and lower odds of 3-month mortality (adjusted OR = 0.80, 95% CI = 0.66-0.97) compared to dMT. The two groups did not differ in functional improvement (adjusted cOR = 1.24, 95% CI = 0.89-1.74) or symptomatic intracranial hemorrhage (adjusted OR = 0.87, 95% CI = 0.61-1.25). INTERPRETATION: BT appears to be associated with improved functional independence without evidence for safety concerns, compared to dMT, for AIS patients with LVO. ANN NEUROL 2019;86:395-406.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Katsanos AH, Malhotra K, Goyal N, et al. Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions. Ann Neurol. 2019. PMID: 31282044. doi:10.1002/ana.25544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。